JUNALIZA 20 mg/10 mg, hard capsule 30 capsules
Active ingredients: Atorvastatin, Atorvastatin calcium trihydrate, Ezetimibe
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule30 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- JUNALIZA 20 mg/10 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 gélule(s)
- Marketing authorisation holder
- EGIS PHARMACEUTICALS (HONGRIE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Feb 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63501238CIP73026663CIP133400930266632Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ATORVASTATINEgélule | 20 mg · une gélule | FT |
| ÉZÉTIMIBEgélule | 10 mg · une gélule | SA |
| ATORVASTATINE CALCIQUE TRIHYDRATÉEgélule | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.